Huaxia Eye Hospital Group Co.,Ltd. (SHE:301267)

Market Cap	15.41B +3.9%
Revenue (ttm)	4.12B +0.6%
Net Income	441.43M -16.6%
EPS	0.53 -16.0%
Shares Out	832.47M
PE Ratio	35.00
Forward PE	33.05
Dividend	0.18 (0.96%)
Ex-Dividend Date	Dec 22, 2025

Volume	3,471,600
Average Volume	4,607,084
Open	19.05
Previous Close	19.04
Day's Range	18.97 - 19.18
52-Week Range	17.46 - 23.17
Beta	0.53
RSI	42.97
Earnings Date	Apr 28, 2026

About Huaxia Eye Hospital Group

Huaxia Eye Hospital Group Co.,Ltd. operates an ophthalmic medical chain in China and internationally. The company provides general ophthalmology diagnosis and treatment services for patients with ophthalmic diseases; and myopia prevention and intervention work to the public. It offers services in the areas of cataract, refraction, fundus, strabismus and amblyopia, pediatric ophthalmology, ocular surface, glaucoma, orbital and ocular tumors, and ocular trauma. The company was founded in 1997 and is based in Xiamen, China.

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1997
• Employees: 7,883
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301267

Financial Performance

In 2024, Huaxia Eye Hospital Group's revenue was 4.03 billion, an increase of 0.35% compared to the previous year's 4.01 billion. Earnings were 428.64 million, a decrease of -35.63%.